HomeStock ScreenerInnova Captab

Innova Captab Share Price | Innova Captab Stock Screener

INNOVACAP Pharmaceuticals
Share Price NSE
₹846.20
▲ 2.70 (0.32%)
2026-05-27 00:00:00
Share Price BSE
₹847.65
▲ 2.05 (0.24%)
2026-05-27 00:00:00
As of May 27, 2026, the Innova Captab share price (NSE: INNOVACAP) is ₹846.20 on NSE and ₹847.65 on BSE, up 0.32% from the previous close, with shares trading between ₹841.00 and ₹870.00, and a 52-week range of ₹644.75–₹945.45. Check INNOVACAP annual price range for the annual price range and momentum. Use the Innova Captab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Innova Captab Market Cap ₹4,826.92 Cr.
INNOVACAP P/E Ratio (TTM) 34.44
Innova Captab P/B Ratio 4.46
EPS (TTM) ₹24.63
Dividend Yield -
Debt to Equity 0.33
INNOVACAP 52 Week High ₹945.45
Innova Captab 52 Week Low ₹644.75
Operating Margin 15.00%
Profit Margin 8.46%
INNOVACAP Revenue (TTM) ₹449.00
EBITDA ₹67.00
Net Income ₹38.00
Total Assets ₹1,837.00
Total Equity ₹1,091.00

Innova Captab Share Price Chart

Screen Innova Captab share price with an interactive chart. Analyse INNOVACAP price trends and volatility across different timeframes.

Innova Captab Company Profile - Fundamental Screener

Screen Innova Captab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INNOVACAP shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE0DUT01020

Innova Captab Balance Sheet Screener

Screen INNOVACAP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019
Assets
Total Assets 1,837 1,580 1,321 704 576 370 245 0
Current Assets 923 696 580 443 379 271 171 0
Fixed Assets 840 830 358 183 183 79 73 0
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 252 268 225 150 72 10 14 0
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 1,091 959 831 277 209 145 110 0
Share Capital 57 57 57 48 12 12 12 0
Reserves & Surplus 1,034 902 774 229 197 133 98 0

Innova Captab Income Statement Screener - Profit & Revenue Analysis

Screen Innova Captab income statement and profit fundamentals. Analyze INNOVACAP quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Innova Captab share price evaluation.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Sept
Revenue 449 318 356 385 452 268 296 320 321 244 234 286 305 217 244
Expenses 383 267 299 329 381 225 252 269 270 214 202 243 258 197 211
EBITDA 67 51 57 56 71 44 44 52 51 29 32 44 47 21 33
Operating Profit % 15.00% 15.00% 15.00% 14.00% 15.00% 15.00% 14.00% 16.00% 15.00% 11.00% 13.00% 14.00% 15.00% 9.00% 13.00%
Depreciation 11 10 11 11 11 3 5 5 5 3 3 5 5 3 3
Interest 5 2 3 6 4 1 0 0 0 5 5 9 7 3 5
Profit Before Tax 51 39 43 39 56 40 39 47 46 21 25 30 35 15 25
Tax 13 10 12 10 14 11 10 12 11 4 7 7 10 2 6
Net Profit 38 30 31 30 42 29 30 35 34 17 18 23 25 13 19
EPS 6.65 5.17 5.42 5.18 7.37 5.02 5.15 6.12 5.97 3.59 3.67 4.77 4.39 108.91 3.91

Innova Captab Cash Flow Screener - Liquidity Fundamentals

Screen INNOVACAP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March
Operating Activities 64 146 67 59 42 31 19
Investing Activities -152 -499 -91 -188 -20 -6 -9
Financing Activities 92 361 27 125 -19 -23 -9
Net Cash Flow 4 8 3 -5 3 2 1

Innova Captab Shareholding Pattern Screener

See Innova Captab shareholding pattern with promoter, FII, and DII holdings. Check Innova Captab promoter holding and ownership changes for INNOVACAP on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 50.90% 50.90% 50.90% 50.90% 50.90% 50.90% 50.90% 50.90%
FII Holding 0.23% 0.34% 0.23% 0.08% 0.11% 1.94% 1.19% 1.01%
DII Holding 20.14% 19.76% 19.67% 20.17% 20.24% 20.77% 21.23% 20.61%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 27.11% 27.62% 27.71% 27.35% 27.22% 25.47% 25.80% 26.00%
Other Holding 1.62% 1.37% 1.49% 1.50% 1.53% 0.91% 0.88% 1.48%
Shareholder Count 36,965 39,996 41,014 40,245 38,691 39,396 35,115 32,254

Innova Captab Share Dividend Screener - Share Yield Analysis

Check Innova Captab dividend history with payout and yield data. View Innova Captab dividend details including ex-dates and amounts for INNOVACAP stock.
No dividends declared by Innova Captab.

Innova Captab Stock Index Membership

See which indices include Innova Captab stock. Check INNOVACAP index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY IPO
NIFTY MICROCAP250
NIFTY TOTAL MKT

Innova Captab Market Events Screener - Corporate Actions

Get Innova Captab corporate actions including splits, bonuses, and buybacks. Check Innova Captab stock events that may affect INNOVACAP share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 16.12%
2026-05-07 2026-05-07 Quarterly Result Announcement NA 20.86%
2026-01-30 2026-01-30 Dividend ₹ 2.00 /share 3.53%
2026-01-23 2026-01-23 Quarterly Result Announcement NA -3.70%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -1.75%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 3.01%
2025-07-31 2025-07-31 Annual General Meeting NA 8.82%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 9.28%
2025-02-05 2025-02-05 Quarterly Result Announcement NA 12.54%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 13.66%

Innova Captab Competitors Screener - Peer Comparison

Screen INNOVACAP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 441,670 40.42 58,220 6.38% 11,565 54.06
Divis Laboratories 179,271 73.73 10,560 8.73% 2,520 57.07
Torrent Pharmaceuticals 150,679 66.80 13,753 19.18% 2,028 56.43
Cipla 114,503 29.26 27,712 -2.46% 3,783 64.74
Dr Reddys Laboratories 110,832 26.24 33,593 -0.44% 3,998 56.54
Zydus Life Science 108,578 20.40 26,720 13.65% 5,242 74.62
Lupin 103,566 19.46 27,488 19.98% 5,345 45.18
Mankind Pharma 100,047 52.84 14,278 12.03% 1,750 55.67
Aurobindo Pharma 84,867 24.29 33,385 3.21% 3,376 52.40
Laurus Labs 74,171 81.46 6,813 21.03% 884 80.00

Innova Captab Company Announcements - News Screener

Screen INNOVACAP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Committee Of The Board -
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Audit Committee Of The Board -
2026-05-28 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-05-28 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-28 Board Meeting Outcome for Pursuant To Regulation 30 We Wish To Inform You That The Board Of Directors Of The Company At Its Meeting Held Today I.E. On Monday 25Th May 2026 Inter-Alia Considered The Reappointment Of Auditors Directors And Approval Of AGM N -
2026-05-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-05-14 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-05-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-05-07 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-05-07 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-05-07 Outcome Of The Board Meeting Held Today I.E. 07Th May 2026 -
2026-05-07 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th May 2026 -
2026-04-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-04-29 Board Meeting Intimation for Intimation Of Board Meeting Under Regulations 29 Of The SEBI (LODR) Regulations 2015 For Consideration Of Audited (Standalone And Consolidated) Financial Results For The Quarter And Financial Year Ended 31St March 2026. -
2026-04-29 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-04-14 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-04-14 Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015 -
2026-04-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-02 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -